HomeProductsBuilding BlocksHeterocyclic ScaffoldsTetrahydropyransKanamycin
Chemical structure of CAS 8063-07-8

Kanamycin

In Stock•Starting at $34 for 250 mg•Purity ≥ 98%
CAS No.8063-07-8
MDL No.MFCD00070289
MFC18H36N4O11
MW484.50
InChI KeySBUJHOSQTJFQJX-NOAMYHISSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
250 mg98%$34In Stock
1 g98%$84In Stock
5 g98%$277In Stock
25 g98% (mix)$1138In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Kanamycin A is a member of the kanamycin family. It functions as a bacterial metabolite and is the conjugate base of kanamycin A(4+).

CAS No.8063-07-8
Product NameKanamycin

Associated Conditions

tuberculosis·colorectal neoplasm·multidrug-resistant tuberculosis·osteomyelitis·bacterial disease·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method.

Antimicrobial agents and chemotherapy • Vol. 45, Issue 6 • 2001
PMID: 11353658PMC: PMC90578DOI: 10.1128/AAC.45.6.1934-1936.2001

Inhibition of the HIV-1 rev-RRE complex formation by unfused aromatic cations.

Bioorganic & medicinal chemistry • Vol. 9, Issue 5 • 2001
PMID: 11377168DOI: 10.1016/s0968-0896(00)00344-8

Overexpression of copper/zinc-superoxide dismutase protects from kanamycin-induced hearing loss.

Audiology & neuro-otology • Vol. 6, Issue 3 • 2001
PMID: 11474137DOI: 10.1159/000046818

Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs.

Biochemical pharmacology • Vol. 59, Issue 3 • 2000
PMID: 10609550DOI: 10.1016/s0006-2952(99)00253-1

Documentation

Similar Products